BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37875555)

  • 1. Anti-tumor activity of a recombinant measles virus against canine lung cancer cells.
    Tamura K; Fujiyuki T; Moritoh K; Akimoto H; Iizuka K; Sato H; Asano K; Yoneda M; Kai C
    Sci Rep; 2023 Oct; 13(1):18168. PubMed ID: 37875555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells.
    Fujiyuki T; Yoneda M; Amagai Y; Obayashi K; Ikeda F; Shoji K; Murakami Y; Sato H; Kai C
    Oncotarget; 2015 Sep; 6(28):24895-903. PubMed ID: 26317644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor activity of an oncolytic measles virus against canine urinary bladder transitional cell carcinoma cells.
    Iizuka K; Shoji K; Fujiyuki T; Moritoh K; Tamura K; Yoshida A; Sato H; Yoneda M; Asano K; Kai C
    Res Vet Sci; 2020 Dec; 133():313-317. PubMed ID: 33183781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles virus selectively blind to signaling lymphocyte activation molecule as a novel oncolytic virus for breast cancer treatment.
    Sugiyama T; Yoneda M; Kuraishi T; Hattori S; Inoue Y; Sato H; Kai C
    Gene Ther; 2013 Mar; 20(3):338-47. PubMed ID: 22717740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles virus selectively blind to signaling lymphocyte activity molecule has oncolytic efficacy against nectin-4-expressing pancreatic cancer cells.
    Awano M; Fujiyuki T; Shoji K; Amagai Y; Murakami Y; Furukawa Y; Sato H; Yoneda M; Kai C
    Cancer Sci; 2016 Nov; 107(11):1647-1652. PubMed ID: 27561180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of new therapy for canine mammary cancer with recombinant measles virus.
    Shoji K; Yoneda M; Fujiyuki T; Amagai Y; Tanaka A; Matsuda A; Ogihara K; Naya Y; Ikeda F; Matsuda H; Sato H; Kai C
    Mol Ther Oncolytics; 2016; 3():15022. PubMed ID: 27119113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response elicited in the tumor microenvironment upon rMV-SLAMblind cancer virotherapy.
    Moritoh K; Shoji K; Amagai Y; Fujiyuki T; Sato H; Yoneda M; Kai C
    Cancer Sci; 2023 May; 114(5):2158-2168. PubMed ID: 36715555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant SLAMblind Measles Virus Is a Promising Candidate for Nectin-4-Positive Triple Negative Breast Cancer Therapy.
    Fujiyuki T; Amagai Y; Shoji K; Kuraishi T; Sugai A; Awano M; Sato H; Hattori S; Yoneda M; Kai C
    Mol Ther Oncolytics; 2020 Dec; 19():127-135. PubMed ID: 33145396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic Activity of a Recombinant Measles Virus, Blind to Signaling Lymphocyte Activation Molecule, Against Colorectal Cancer Cells.
    Amagai Y; Fujiyuki T; Yoneda M; Shoji K; Furukawa Y; Sato H; Kai C
    Sci Rep; 2016 Apr; 6():24572. PubMed ID: 27090874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant measles virus vaccine strain rMV-Hu191 has oncolytic effect against human gastric cancer by inducing apoptotic cell death requiring integrity of lipid raft microdomains.
    Lv Y; Zhou D; Hao XQ; Zhu MY; Zhang CD; Zhou DM; Wang JH; Liu RX; Wang YL; Gu WZ; Shen HQ; Chen X; Zhao ZY
    Cancer Lett; 2019 Sep; 460():108-118. PubMed ID: 31226409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant measles virus induces cytolysis of cutaneous T-cell lymphoma in vitro and in vivo.
    Künzi V; Oberholzer PA; Heinzerling L; Dummer R; Naim HY
    J Invest Dermatol; 2006 Nov; 126(11):2525-32. PubMed ID: 16960554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles vaccine strains for virotherapy of non-small-cell lung carcinoma.
    Patel MR; Jacobson BA; Belgum H; Raza A; Sadiq A; Drees J; Wang H; Jay-Dixon J; Etchison R; Federspiel MJ; Russell SJ; Kratzke RA
    J Thorac Oncol; 2014 Aug; 9(8):1101-10. PubMed ID: 25157763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor suppressor in lung cancer-1 (TSLC1) mediated by dual-regulated oncolytic adenovirus exerts specific antitumor actions in a mouse model.
    Lei W; Liu HB; Wang SB; Zhou XM; Zheng SD; Guo KN; Ma BY; Xia YL; Tan WS; Liu XY; Wang YG
    Acta Pharmacol Sin; 2013 Apr; 34(4):531-40. PubMed ID: 23503473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatin.
    Hutzen B; Bid HK; Houghton PJ; Pierson CR; Powell K; Bratasz A; Raffel C; Studebaker AW
    BMC Cancer; 2014 Mar; 14():206. PubMed ID: 24646176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRP6 Is a Functional Receptor for Attenuated Canine Distemper Virus.
    Gradauskaite V; Inglebert M; Doench J; Scherer M; Dettwiler M; Wyss M; Shrestha N; Rottenberg S; Plattet P
    mBio; 2023 Feb; 14(1):e0311422. PubMed ID: 36645301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered measles virus as a novel oncolytic therapy against prostate cancer.
    Msaouel P; Iankov ID; Allen C; Morris JC; von Messling V; Cattaneo R; Koutsilieris M; Russell SJ; Galanis E
    Prostate; 2009 Jan; 69(1):82-91. PubMed ID: 18973133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.
    Achard C; Boisgerault N; Delaunay T; Roulois D; Nedellec S; Royer PJ; Pain M; Combredet C; Mesel-Lemoine M; Cellerin L; Magnan A; Tangy F; Grégoire M; Fonteneau JF
    Oncotarget; 2015 Dec; 6(42):44892-904. PubMed ID: 26539644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors.
    Studebaker AW; Hutzen B; Pierson CR; Shaffer TA; Raffel C; Jackson EM
    Neuro Oncol; 2015 Dec; 17(12):1568-77. PubMed ID: 25838138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical efficacy of the oncolytic measles virus expressing the sodium iodide symporter in iodine non-avid anaplastic thyroid cancer: a novel therapeutic agent allowing noninvasive imaging and radioiodine therapy.
    Reddi HV; Madde P; McDonough SJ; Trujillo MA; Morris JC; Myers RM; Peng KW; Russell SJ; McIver B; Eberhardt NL
    Cancer Gene Ther; 2012 Sep; 19(9):659-65. PubMed ID: 22790962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant measles virus vaccine rMV-Hu191 exerts an oncolytic effect on esophageal squamous cell carcinoma via caspase-3/GSDME-mediated pyroptosis.
    Wu A; Li Z; Wang Y; Chen Y; Peng J; Zhu M; Li Y; Song H; Zhou D; Zhang C; Lv Y; Zhao Z
    Cell Death Discov; 2023 May; 9(1):171. PubMed ID: 37202386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.